Medicana Health Group, renowned for its integrated healthcare delivery, is set to broaden its horizons by introducing its services to the UK market, responding to the growing demand for high-calibre healthcare.
The surge in individuals seeking private healthcare post-COVID has prompted Medicana to bring its signature approach of individualised care to the UK. Central to Medicana’s philosophy is “active listening and personalised attention at every stage of the patient’s journey,” ensuring a customised experience from the first consultation through to aftercare. This model, which has garnered success in Türkiye, aims to set a new benchmark in private healthcare in the UK.
Tapping into the UK’s £282 Billion Healthcare Market
The UK’s private healthcare sector saw a resurgence in 2021 and 2022, following the COVID-19 pandemic, largely fuelled by an uptick in individuals paying for their own treatments. More people than ever are choosing private healthcare to circumvent NHS waiting times and leverage the superior services of the independent sector. The 2022 healthcare expenditure in the UK, as per an Akeso report, stood at an estimated £282 billion, with public spending accounting for approximately 80% and private spending making up the remaining 20%.
Seizing the opportunity presented by this growth, Medicana aims to deploy its in-depth knowledge and comprehensive care offerings to penetrate the UK’s expanding private healthcare market. By introducing its validated healthcare model, encompassing everything from advanced diagnostic procedures to specialised care, Medicana is set to meet the surging demand for top-tier private healthcare. The organisation’s commitment to outstanding care, along with its forward-thinking approach to patient treatment, positions Medicana as an ideal response to the UK’s healthcare challenges.
A Global Healthcare Giant Enters the UK
Medicana Health Group annually serves over 5.5 million patients globally, operating 16 hospitals with extensive facilities. This demonstrates their vast experience and capability in providing superior healthcare services to a diverse international patient demographic. Medicana’s foray into the UK market is anticipated to revolutionise patient care, offering a more humane, efficient, and customised healthcare experience.
Medicana boasts over 30 years of medical excellence, with a wide spectrum of services in key areas such as Oncology, Organ Transplantation, Neurosurgery, and more. Additionally, since 2016, Medicana has expanded into the educational sector, offering a broad educational curriculum spanning from early childhood education to university level.
